Literature DB >> 27236678

Optimization of Mesenchymal Stem Cells to Increase Their Therapeutic Potential.

Minh Quan Vu1,2, Shant Der Sarkissian1,2, Melanie Borie1, Pierre-Olivier Bessette2, Nicolas Noiseux3,4,5.   

Abstract

The heart which has limited renewal and regenerative capacity is a prime target for cellular therapy. Stem cell transplantation has emerged as a promising therapeutic strategy to improve healing of the ischemic heart, repopulate the injured myocardium, and restore cardiac function. However, clinical usefulness is impacted by the quality and quantity of delivered cells, the suboptimal manipulations prior to transplantation, and the general poor viability of the cells transferred particularly to an ischemic microenvironment. Focus is now on developing new ways to enhance stem cell renewal and survival capacity before transplant. This can be done by physical, chemical, pharmacological, or genetic manipulation of cells followed by accurate evaluation of conditioning methods by validated tests.This chapter covers the proper handling of mesenchymal stem cells (human and rat lines) and methodologies to evaluate efficacy and the translational potential of conditioning methods. Specifically, we will cover stem cell culture methods, preconditioning protocols, viability assessment in hypoxic and oxidative challenges as encountered in an ischemic microenvironment, and the proliferative capacity of cells.

Entities:  

Keywords:  Cardiovascular disease; Mesenchymal stem cells; Myocardial infarct; Preconditioning; Proliferation; Regenerative medicine; Viability

Mesh:

Substances:

Year:  2016        PMID: 27236678     DOI: 10.1007/978-1-4939-3584-0_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Human umbilical cord mesenchymal stem cells polarize RAW264.7 macrophages to an anti-inflammatory subpopulation.

Authors:  Yu Xu; Hongxing Luo; Fang Chen; Ya'nan Shi; Mengna Sun
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells.

Authors:  Natasha Salame; Jean-Pierre Bikorimana; Nehme El-Hachem; Wael Saad; Mazen Kurdi; Jing Zhao; Nicoletta Eliopoulos; Riam Shammaa; Moutih Rafei
Journal:  Stem Cell Res Ther       Date:  2022-01-10       Impact factor: 6.832

3.  Hypoxia, a dynamic tool to amplify the gingival mesenchymal stem cells potential for neurotrophic factor secretion.

Authors:  Shankargouda Patil; Hytham N Fageeh; Hammam Ibrahim Fageeh; Wael Ibraheem; Abdulrahman Saleh Alshehri; Ashraf Al-Brakati; Salem Almoammar; Mohammad Almagbol; Harisha Dewan; Samar Saeed Khan; Hosam Ali Baeshen; Vikrant R Patil; A Thirumal Raj; Shilpa Bhandi
Journal:  Saudi J Biol Sci       Date:  2022-02-26       Impact factor: 4.052

4.  Mesenchymal Stromal Stem Cell-Derived Microvesicles Enhance Tumor Lysate Pulsed Dendritic Cell Stimulatedzzm321990Autologous T lymphocyte Cytotoxicity

Authors:  Nasim Rahmani Kukia; Reza Alipanah-Moghadam; Nowruz Delirezh; Mohammad Mazani
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.